{
  "id": "38517",
  "attachmentHtml": "\n<p><strong>PC Number: </strong>2019-1197<br></p><p><strong>Date: </strong>2019-08-07</p><hr><p>\n\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\nWhereas, pursuant to subsection 101(2) of the&nbsp;<em>Patent Act</em>, the Minister of Health has consulted with provincial ministers of the Crown responsible for health and&nbsp;with such representatives of consumer groups and representatives of the&nbsp;pharmaceutical industry as the Minister considers appropriate;\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\n&nbsp;\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\nTherefore, Her Excellency the Governor General in&nbsp;Council, on the recommendation of the Minister of Health, pursuant to subsection 101(1) of the <em>Patent Act</em>, makes the&nbsp;annexed <em>Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements)</em>.  \n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\n&nbsp;</p>\n<br style=\"page-break-before:always\">\n<p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\n&nbsp;\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\nAttendu que, conformément au paragraphe&nbsp;101(2) de la <em>Loi sur les brevets</em>, la ministre de la Santé a consulté les&nbsp;ministres provinciaux responsables de la santé et les&nbsp;représentants des groupes de consommateurs et de l’industrie&nbsp;pharmaceutique qu’elle juge utile de consulter,\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\n&nbsp;\n</p><p style=\"text-indent:1.00in;text-align:left;margin-top:0.00in;margin-bottom:0.00in;\">\nÀ ces causes, sur recommandation de la ministre de&nbsp;la Santé et en vertu du paragraphe 101(1) de la <em>Loi sur les&nbsp;brevets</em>, Son Excellence la Gouverneure générale en conseil prend le <em>Règlement modifiant le Règlement sur les médicaments brevetés (facteurs additionnels et exigences supplémentaires relatives à la fourniture de renseignements)</em>, ci-après.</p>\n\n<p></p><form method=\"post\" action=\"index.php\"><input type=\"submit\" value=\"Back to Form\" class=\"btn btn-primary\" name=\"return\"></form>\t\t\n        <!-- end main content -->\n        <div id=\"def-preFooter\">\n       \t\t<!-- Write closure fall-back static file -->\n             <!--Response.Write readFile(\"StaticFallbackFiles/gcweb/preFooter-\" & $lang & \".html\") -->\n        </div>\n\t\t<!-- Write closure template -->\n        <script type=\"text/javascript\">\n            var defPreFooter = document.getElementById(\"def-preFooter\");\n            defPreFooter.outerHTML = wet.builder.preFooter({\n                cdnEnv: \"prod\",\n                dateModified: \"2022-07-11\",\n                showPostContent: true\n            });\n        </script>\n    ",
  "attachmentText": "\nPC Number: 2019-1197Date: 2019-08-07\n\n\nWhereas, pursuant to subsection 101(2) of the Patent Act, the Minister of Health has consulted with provincial ministers of the Crown responsible for health and with such representatives of consumer groups and representatives of the pharmaceutical industry as the Minister considers appropriate;\n\n \n\nTherefore, Her Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to subsection 101(1) of the Patent Act, makes the annexed Regulations Amending the Patented Medicines Regulations (Additional Factors and Information Reporting Requirements).  \n\n \n\n\n \n\nAttendu que, conformément au paragraphe 101(2) de la Loi sur les brevets, la ministre de la Santé a consulté les ministres provinciaux responsables de la santé et les représentants des groupes de consommateurs et de l’industrie pharmaceutique qu’elle juge utile de consulter,\n\n \n\nÀ ces causes, sur recommandation de la ministre de la Santé et en vertu du paragraphe 101(1) de la Loi sur les brevets, Son Excellence la Gouverneure générale en conseil prend le Règlement modifiant le Règlement sur les médicaments brevetés (facteurs additionnels et exigences supplémentaires relatives à la fourniture de renseignements), ci-après.\n\n\t\t\n        \n        \n       \t\t\n             \n        \n\t\t\n        \n    "
}